Highly efficient gene transfer into murine liver achieved by intravenous administration of naked Epstein-Barr virus (EBV)-based plasmid vectors

Gene Therapy

Volumn 8, Issue 19, 2001, Pages 1508-1513

  Cui, F D ^a   Kishida, T ^a   Ohashi, S ^a   Asada, H ^a   Yasutomi, K ^a   Satoh, E ^a   Kubo, T ^a   Fushiki, S ^a   Imanishi, J ^a   Mazda, O ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

Episomal vector; Epstein Barr virus based plasmid vector; Gene therapy; Hydrodynamics; Liver; Naked DNA

Indexed keywords

BETA GALACTOSIDASE; CELL NUCLEUS ANTIGEN; EPSTEIN BARR VIRUS ANTIGEN; GENE PRODUCT; LUCIFERASE; PLASMID DNA; PLASMID VECTOR; VIRUS DNA; VIRUS VECTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; EPSTEIN BARR VIRUS; GENE EXPRESSION; GENE REPLICATION; GENE SEQUENCE; GENE TARGETING; GENE THERAPY; GENE TRANSFER; GENETIC PROCEDURES; GENETIC TRANSFECTION; IN VITRO STUDY; IN VIVO STUDY; LIVER; LIVER CELL; MARKER GENE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SIGNAL TRANSDUCTION; STAINING; TAIL; VIRUS GENE; VIRUS REPLICATION;

ANIMALS; BETA-GALACTOSIDASE; FEMALE; GENE EXPRESSION; GENE THERAPY; GENES, VIRAL; HERPESVIRUS 4, HUMAN; INJECTIONS, INTRAVENOUS; LIVER; LUCIFERASES; MICE; MICE, INBRED BALB C; TRANSFECTION; VACCINES, DNA;

ANIMALIA; DNA VIRUSES; HUMAN HERPESVIRUS 4; MURINAE;

EID: 0034777596     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3301551     Document Type: Article

References (38)

1. Direct gene transfer into mouse muscle in vivo
2. Somatic gene therapy in the cardiovascular system
3. Expression of recombinant genes in myocardium in vivo after direct injection of DNA
4. Intratracheal gene delivery to the mouse airway: Characterization of plasmid DNA expression and pharmacokinetics
5. Direct cutaneous gene delivery in a human genetic skin disease
6. Gene expression following direct injection of DNA into liver
7. Naked DNA delivered intraportally expresses efficiently in hepatocytes
8. Expression of naked plasmid DNA injected into the afferent and efferent vessels of rodent and dog livers
9. Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA
10. High levels of foreign gene expression in hepatocytes after tail vein injections of naked plasmid DNA
11. Long-term expression of human alpha1-antitrypsin gene in mouse liver achieved by intravenous administration of plasmid DNA using a hydrodynamics-based procedure
12. Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells
13. Human artificial episomal chromosomes for cloning large DNA fragments in human cells
14. Long-term gene expression from autonomously replicating vectors in mammalian cells
15. Functional domains of Epstein-Barr virus nuclear antigen EBNA-1
16. Epstein-Barr virus nuclear antigen 1 forms a complex with the nuclear transporter karyopherin alpha2
17. A nuclear matrix attachment region organizes the Epstein-Barr viral plasmid in Raji cells into a single DNA domain
18. An EBNA-1-dependent enhancer acts from a distance of 10 kilobase pairs to increase expression of the Epstein-Barr virus LMP gene
19. oriP is essential for EBNA gene promoter activity in Epstein-Barr virus-immortalized lymphoblastoid cell lines
20. Multiple EBNA1-binding sites are required to form an EBNA1-dependent enhancer and to activate a minimal replicative origin within oriP of Epstein-Barr virus
21. + cells by transfecting EBV-based episomal vectors
22. Direct intra-cardiomuscular transfer of beta2-adrenergic receptor gene augments cardiac output in cardiomyopathic hamsters
23. Cationic polymer-mediated genetic transduction into cultured human chondrosarcoma-derived HCS-2/8 cells
24. Use of EBV-based vector/HVJ-liposome complex vector for targeted gene therapy of EBV-associated neoplasms
25. Highly efficient suicide gene expression in hepatocellular carcinoma cells by Epstein-Barr virus-based plasmid vectors combined with polyamidoamine dendrimer
26. Effective suicide gene therapy in vivo by EBV-based plasmid vector coupled with polyamidoamine dendrimer
27. Targeted killing of carcinoembryonic antigen (CEA)-producing cholangiocarcinoma cells by polyamidoamine dendrimer-mediated transfer of an Epstein-Barr virus (EBV)-based plasmid vector carrying the CEA promoter
28. Efficient gene transduction by Epstein-Barr virus-based vectors coupled with cationic liposome and HVJ-liposome
29. Gene transfer in vitro and in vivo with Epstein-Barr virus-based episomal vector results in markedly high transient expression in rodent cells
30. In vivo gene gun-mediated transduction into rat heart with Epstein-Barr virus-based episomal vectors
31. Epstein-Barr virus-based vectors that replicate in rodent cells
32. Sustained transgene expression in vitro and in vivo using an Epstein-Barr virus replicon vector system combined with HVJ liposomes
33. Enhancement of transgene expression by cotransfection of oriP plasmid with EBNA-1 expression vector
34. Hypothesis: Naked plasmid DNA is taken up by cells in vivo by a receptor-mediated process
35. Intravenous injection of naked DNA encoding secreted flt3 ligand dramatically increases the number of dendritic cells and natural killer cells in vivo
36. Efficient expression of naked DNA delivered intraarterially to limb muscles of nonhuman primates
37. Extremely efficient gene transfection into lympho-hematopoietic cell lines by Epstein-Barr virus-based vectors
38. Efficient selection for high-expression transfectants with a novel eukaryotic vector